A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years
Clinical trial NCT05561673 · COMPLETED
Trial details
- NCT number
- NCT05561673
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-04
- Primary completion
- 2024-11-29
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.